Consistently, LPC 18:2 markedly increased Il17a and Il17f mRNA expression and showed a trend toward higher Rorc levels, although the latter did not reach statistical significance ( Fig. 5 E ) .
← all excerpts
Lysophosphatidylcholine 18:2 exacerbates Th17-dominant inflammation in obese asthma.
1
—
—